✦ LIBER ✦

National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral-naïve patients

✍ Scribed by E Hart; H Curtis; E Wilkins; M Johnson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determinants of clinical progression in

✍ F Bonnet; R Thiébaut; G Chêne; D Neau; J-L Pellegrin; P Mercié; J Beylot; F Dabi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Lipoprotein changes in HIV-infected anti

✍ James H. Stein; Lauren Komarow; Bruno R. Cotter; Judith S. Currier; Michael P. D 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 101 KB

Insights into reasons for discontinuatio

✍ P Cicconi; A Cozzi-Lepri; A Castagna; EM Trecarichi; A Antinori; F Gatti; G Cass 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Nevirapine- versus efavirenz-based highl

✍ W Manosuthi; S Sungkanuparph; A Vibhagool; S Rattanasiri; A Thakkinstian 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Antiretroviral therapy for treatment-naï

✍ Jennifer A. Johnson; Paul E. Sax 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 307 KB

Evaluation of the impact of highly activ

✍ L Al-Harthi; J Voris; BK Patterson; S Becker; J Eron; KY Smith; R D'amico; D Mil 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB